Skip to content

acute coronary syndrome patients treated with different lowwing-lipid therapies, a randomized controlled clinical trial

acute coronary syndrome patients treated with different lowwing-lipid therapies, a randomized controlled clinical trial

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IPR-15006636
Enrollment
Unknown
Registered
2015-06-22
Start date
2015-07-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients with acute coronary syndrome and lipid nonattainment

Interventions

Sponsors

Second Affiliated Hospital of Chongqing Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1. Age 18-80 years old, male or female; 2. The 2013ACC / AHA ACS cardiovascular diagnostic criteria, the first onset of symptoms and who meet one of the following conditions: (1) unstable angina; (2) Non-ST segment elevation myocardial infarction; (3) ST segment elevation myocardial infarction.

Exclusion criteria

Exclusion criteria: 1. PCI with previous history of surgery; lipid-lowering therapy in patients has been performed; 2. with other heart disease who have severe heart failure (heart failure I-IV grade); 3. recent surgery or trauma persons; 4. The combined acute and chronic infections, blood diseases, cancer, and other immune system diseases of connective tissue rheumatism; 5. severe liver dysfunction (ALT> 3*ULN or Ccr <30ml / min); 6. myopathy or myositis patients and contraindicated in patients with statin use; 7. Use contraindicated in patients with ezetimibe.

Design outcomes

Primary

MeasureTime frame
ALT;AST;CK-MB;CK;LDH;BUN;Ccr;TC;TG;LDH;

Countries

ZhongGuo

Contacts

Public ContactQiang She
qshe98@hotmail.com+86 13508393602

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026